|
|
REVIEW
|
|
Prophylaxis of skeletal complications of bone metastases or multiple myeloma
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Discount contracts: consequences for patients
Autologous blood therapy ORTHOKIN: what´s new?
|
|
|
IN BRIEF
|
|
Drospirenone-containing pill YAZ not additionally approved against acne
Pharmaceutical industry spends up to 91 million € per year for lobbying in the EU
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Lymphoma with natalizumab (TYSABRI)
|
|
Polyneuropathy and visual disturbance with dronedarone (MULTAQ) |
|
|
SIDE EFFECTS
|
|
Preventing accidental poisoning with opioid patches
Retinal detachment with gyrase inhibitors
|
|